WHO Suspends Remdesivir from ‘Prequalification List’ of Medicines Following Warning Against Use for COVID-19 Treatment
Gilead’s Remdesivir, the popular antiviral drug that was widely hailed as a potential treatment for COVID-19, has reportedly been suspended by the World Health Organisation (WHO) from its list of medicines. As per reports, WHO has suspended Gilead’s Remdesivir from its ‘prequalification list’, an official list of medicines used as a standard for procurement by…